North America Biotechnology Reagents & Kits Market Size & Outlook
- Root
- Biotechnology
- Biotechnology Reagents & Kits Market Outlook
- Biotechnology
North America Biotechnology Reagents Kits Market, 2018-2028 (US$B)
Global Market
Related Markets
Ask Prism AI about the biotechnology reagents & kits market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
North America biotechnology reagents & kits market highlights
- The North America biotechnology reagents & kits market generated a revenue of USD 125.3 billion in 2020.
- The market is expected to grow at a CAGR of 16.4% from 2021 to 2028.
- In terms of segment, detection kits was the largest revenue generating kit type in 2020.
- Detection Kits is the most lucrative kit type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.
North America data book summary
| Market revenue in 2020 | USD 125.3 billion |
| Market revenue in 2028 | USD 423.2 billion |
| Growth rate | 16.4% (CAGR from 2020 to 2028) |
| Largest segment | Detection kits |
| Fastest growing segment | Detection Kits |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD billion |
| Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
Other key industry trends
- In terms of revenue, North America region accounted for 37.2% of the global biotechnology reagents & kits market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 355.3 billion by 2028.
North America dominated the revenue share in 2021 owing to presence of major biotechnology & pharmaceutical companies offering reagents and kits for molecular biology, environmental biology, industrial biology, & other biotechnology fields.
The major pharma companies providing reagents and kits products, operating in this region are Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc; Illumina; Promega Corporation; Becton, Dickinson and Company (BD); and Enzo Life Sciences, Inc. Moreover, several drug developers operating in this region are involved in strategic initiatives aiding market growth.
For instance, in December 2020, Lifespan Biosciences (LSBio) acquired Absolute antibody and its sister company Kerafast. This acquisition was expected to enable Absolute Antibody continue its growth, while delivering better quality recombinant antibody reagents & services.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biotechnology Reagents & Kits Market Scope
Biotechnology Reagents Kits Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| LGC Group | View profile | 1001-5000 | Teddington, Gloucestershire, United Kingdom, Europe | www.lgcgroup.com/ |
| Toyobo Co Ltd | View profile | 12,460 | 2-8, Dojima Hama 2-chome, Kita-ku, Osaka, Japan, 530-8230 | www.toyobo.co.jp |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | neb.com |
North America Biotechnology Reagents & Kits Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biotechnology Reagents & Kits Market Outlook will help companies and investors design strategic landscapes.
Detection Kits was the largest segment with a revenue share of 23.06% in 2020.
Horizon Databook has segmented the North America biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
North America dominated the revenue share in 2021 owing to presence of major biotechnology & pharmaceutical companies offering reagents and kits for molecular biology, environmental biology, industrial biology, & other biotechnology fields.
The major pharma companies providing reagents and kits products, operating in this region are Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc; Illumina; Promega Corporation; Becton, Dickinson and Company (BD); and Enzo Life Sciences, Inc. Moreover, several drug developers operating in this region are involved in strategic initiatives aiding market growth.
For instance, in December 2020, Lifespan Biosciences (LSBio) acquired Absolute antibody and its sister company Kerafast. This acquisition was expected to enable Absolute Antibody continue its growth, while delivering better quality recombinant antibody reagents & services.
- North America Biotechnology Reagents & Kits Market Kit Type Outlook (Revenue, USD BIllion , 2018-2028)
- Purification Kits
- Amplification Kits
- Detection Kits
- Isolation Kits
- Others
- North America Biotechnology Reagents & Kits Market Technology Outlook (Revenue, USD BIllion , 2018-2028)
- LAMP technology
- PCR
- Cell Culture
- Sequencing
- Chromatography
- Electrophoresis
- Flow Cytometry
- Other Technologies
- North America Biotechnology Reagents & Kits Market Tested Parameters Outlook (Revenue, USD BIllion , 2018-2028)
- DNA
- RNA
- Enzymes
- Proteins
- Others
- North America Biotechnology Reagents & Kits Market Micro-Organisms Outlook (Revenue, USD BIllion , 2018-2028)
- Bacteria
- Virus
- Fungi
- Parasites
- North America Biotechnology Reagents & Kits Market Purpose Outlook (Revenue, USD BIllion , 2018-2028)
- On-Site
- Laboratory
- North America Biotechnology Reagents & Kits Market End-use Outlook (Revenue, USD BIllion , 2018-2028)
- Healthcare
- Food & Agriculture
- Natural reseources & Environment
- Industrial Processing
- Others
Reasons to subscribe to Biotechnology Reagents & Kits Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biotechnology Reagents & Kits Market Outlook databook
- Our clientele includes a mix of Biotechnology Reagents & Kits Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America Biotechnology Reagents & Kits Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into North America Biotechnology Reagents & Kits Market Outlook from 2018 to 2028, including revenue numbers, major trends, and company profiles.
North America Biotechnology Reagents Kits Market, 2018-2028 (US$B)
North America biotechnology reagents & kits market statistics, by kit type, 2018-2028 (USD BIllion)
